These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8009056)

  • 1. [Correlation between the serum level of soluble CD16 and the staging of myeloma: study of 214 serums].
    Mathiot C; Grosbois B; Teillaud JL; Tartour E; Mosseri V; Euller-Ziegler L; Daragon A; Michaux JL; Facon T; Bernard JF
    Rev Med Interne; 1993; 14(10):960. PubMed ID: 8009056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between soluble serum CD16 (sCD16) levels and disease stage in patients with multiple myeloma.
    Mathiot C; Teillaud JL; Elmalek M; Mosseri V; Euller-Ziegler L; Daragon A; Grosbois B; Michaux JL; Facon T; Bernard JF
    J Clin Immunol; 1993 Jan; 13(1):41-8. PubMed ID: 8445043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble CD16 (sCD16), a marker of malignancy in individuals with monoclonal gammopathy of undetermined significance (MGUS).
    Mathiot C; Mary JY; Tartour E; Facon T; Monconduit M; Grosbois B; Pollet JP; Michaux JL; Euller Ziegler L; Sautès C; Bataille R; Fridman WH
    Br J Haematol; 1996 Dec; 95(4):660-5. PubMed ID: 8982042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of production of soluble Fc gamma receptors type III in normal and pathological conditions.
    Moldovan I; Galon J; Maridonneau-Parini I; Roman Roman S; Mathiot C; Fridman WH; Sautès-Fridman C
    Immunol Lett; 1999 May; 68(1):125-34. PubMed ID: 10397167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoregulatory circuits in myeloma. Tumor cell cytotoxicity mediated by soluble CD16.
    Hoover RG; Lary C; Page R; Travis P; Owens R; Flick J; Kornbluth J; Barlogie B
    J Clin Invest; 1995 Jan; 95(1):241-7. PubMed ID: 7529259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble CD16 in plasma cell dyscrasias.
    Mathiot C; Galon J; Tartour E; Teillaud JL; Facon T; Bataille R; Fridman WH; Sautès C
    Leuk Lymphoma; 1999 Feb; 32(5-6):467-74. PubMed ID: 10048419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies raised against peptide fragments of CD16 reacting with membrane and soluble form of CD16. I: Production and characterization.
    Mouawad R; Visonneau S; Soubrane C; Hirel PH; Autran B; Marceau-Suissa J; Weil M; Khayat D
    Hybridoma; 1992 Aug; 11(4):447-59. PubMed ID: 1383125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the cleavage site involved in production of plasma soluble Fc gamma receptor type III (CD16).
    Galon J; Moldovan I; Galinha A; Provost-Marloie MA; Kaudewitz H; Roman-Roman S; Fridman WH; Sautès C
    Eur J Immunol; 1998 Jul; 28(7):2101-7. PubMed ID: 9692878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble Fcgamma receptor type III (FcgammaRIII, CD16) triggers cell activation through interaction with complement receptors.
    Galon J; Gauchat JF; Mazières N; Spagnoli R; Storkus W; Lötze M; Bonnefoy JY; Fridman WH; Sautès C
    J Immunol; 1996 Aug; 157(3):1184-92. PubMed ID: 8757624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.
    Lauta VM
    Cancer; 2003 May; 97(10):2440-52. PubMed ID: 12733143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affinity of the interaction between Fc gamma receptor type III (Fc gammaRIII) and monomeric human IgG subclasses. Role of Fc gammaRIII glycosylation.
    Galon J; Robertson MW; Galinha A; Mazières N; Spagnoli R; Fridman WH; Sautès C
    Eur J Immunol; 1997 Aug; 27(8):1928-32. PubMed ID: 9295028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of cytokine and soluble Fc gamma receptor assays in oncology.
    Tartour E; Pannetier C; Mathiot C; Teillaud JL; Sautès C; Kourilsky P; Fridman WH
    Immunol Lett; 1995 Jan; 44(2-3):145-8. PubMed ID: 7797244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble CD16 in the treatment of murine lupus nephritis.
    Watanabe H; Sherris D; Gilkeson GS
    Clin Immunol Immunopathol; 1998 Jul; 88(1):91-5. PubMed ID: 9683555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling status of IgG B cell receptor (IgG BCR) is indicative for an activated state of circulating B cells in multiple myeloma.
    Ilić V; Milosević-Jovcić N; Petrović S; Marković D; Bila J; Bosković D; Stefanović G; Marković O; Glibetić M
    Ann Hematol; 2007 Dec; 86(12):905-12. PubMed ID: 17701175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased sialylation of oligosaccharides on IgG paraproteins--a potential new tumour marker in multiple myeloma.
    Fleming SC; Smith S; Knowles D; Skillen A; Self CH
    J Clin Pathol; 1998 Nov; 51(11):825-30. PubMed ID: 10193323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 in multiple myeloma: correlation with disease activity and Ki-67 proliferation index.
    Thaler J; Fechner F; Herold M; Huber H
    Leuk Lymphoma; 1994 Jan; 12(3-4):265-71. PubMed ID: 8167557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein promotes bone destruction in human myeloma through the CD32-p38 MAPK-Twist axis.
    Yang J; Liu Z; Liu H; He J; Yang J; Lin P; Wang Q; Du J; Ma W; Yin Z; Davis E; Orlowski RZ; Hou J; Yi Q
    Sci Signal; 2017 Dec; 10(509):. PubMed ID: 29233917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stoichiometry and thermodynamics of the interaction between the Fc fragment of human IgG1 and its low-affinity receptor Fc gamma RIII.
    Ghirlando R; Keown MB; Mackay GA; Lewis MS; Unkeless JC; Gould HJ
    Biochemistry; 1995 Oct; 34(41):13320-7. PubMed ID: 7577916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil Fc gamma and complement receptors involved in binding soluble IgG immune complexes and in specific granule release induced by soluble IgG immune complexes.
    Voice JK; Lachmann PJ
    Eur J Immunol; 1997 Oct; 27(10):2514-23. PubMed ID: 9368604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cell frequency and serum cytokine levels in monoclonal gammopathies: correlation of bone marrow granular lymphocytes to prognosis.
    Sawanobori M; Suzuki K; Nakagawa Y; Inoue Y; Utsuyama M; Hirokawa K
    Acta Haematol; 1997; 98(3):150-4. PubMed ID: 9352746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.